Tag: mitochondrial
April 25, 2018
Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone
Reata Pharmaceuticals (Nasdaq:RETA) a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that omaveloxolone potently activates the Keap1/Nrf2 pathway,... March 2, 2018
Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study
Reata Pharmaceuticals (Nasdaq:RETA) a clinical-stage biopharmaceutical company, announced top-line data from the dose-escalation cohorts of the Phase 2 MOTOR trial...
February 13, 2017
What is Longevity Investing?
A look at longevity investing and achieving longevity for life.
December 29, 2016
Top Genetics News Stories of 2016
From precision meds to the ongoing CRISPR-Cas9 saga, here are the top genetics news stories of 2016. We expect each... December 12, 2016
Reata Pharmaceuticals Announces Requested Withdrawal of Registration Statement Due to Adverse Market Conditions
Reata Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced that, due to adverse market conditions, it has requested withdrawal of its... December 6, 2016
Reata Pharmaceuticals Announces Filing of Registration Statement for Proposed Public Offering
Reata Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the... November 9, 2016